Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms
about
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaAssociation between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patientsImproving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin AllergyEmerging threat of multidrug resistant bugs--Acinetobacter calcoaceticus baumannii complex and methicillin resistant Staphylococcus aureus.The antimicrobial effect of Octenidine-dihydrochloride coated polymer tracheotomy tubes on Staphylococcus aureus and Pseudomonas aeruginosa colonisation.Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study.Epidemiology of MRSA and current strategies in Europe and Japan.Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009)Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.Molecular analysis of methicillin-resistant Staphylococcus aureus as a causative agent of bronchopulmonary infection: relation to colonization in the upper respiratory tract.Clonal associations among Staphylococcus aureus isolates from various sites of infectionEconomic impact of antimicrobial resistance.The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.Staphylococcus aureus infections and antibiotic resistance in older adults.De-escalation antimicrobial chemotherapy in critically III patients: pros and cons.The role of telavancin in hospital-acquired pneumonia and ventilator-associated pneumonia.Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".A review of the current place of glycopeptides in turkish medical practiceStaphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse.Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremiaReference group choice and antibiotic resistance outcomes.Predictors of mortality in Staphylococcus aureus BacteremiaTreatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycinClinical impact of methicillin-resistant staphylococcus aureus on bacterial pneumonia: cultivation and 16S ribosomal RNA gene analysis of bronchoalveolar lavage fluid.The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trialImpact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureusDefining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.Meticillin-resistant Staphylococcus aureus and meticillin-susceptible S. aureus pneumonia: comparison of clinical and thin-section CT findings.Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremiaPotential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.Dalbavancin: a novel lipoglycopeptide antibacterial.Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.Review of new guidelines for prophylaxis and treatment of MRSA infections.Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients.
P2860
Q21261829-43196391-19D9-4E2E-B8FB-307ECBDE75ECQ26751621-9BEE9E8C-BEDB-4A8F-828C-AA80ECE67FBAQ26779453-594252F9-5F99-4BB4-A746-9AA0A715DA98Q30428330-6C28F780-3606-44CA-ADBC-C0F3BB583840Q30871030-747262C2-10F7-490F-BF40-87F5530CB61CQ33519083-5CDA6006-B355-47B5-BF8C-9768DBA99486Q33699782-E60EA9D0-6102-4EC9-89F2-A84B5BBB93CDQ33704733-F91BE52E-EDB2-4D17-B2EB-C3C4B2CB84A1Q33773159-AB550F08-0BBB-4F3A-8779-81EB06894462Q33797925-468A74CA-36B7-470D-93D8-E65A88D0D863Q33970086-23943691-DA06-4499-8CEB-4F12C27D7E29Q34005637-021A96C6-BF7D-48B0-86C9-CEFCB16A497EQ34213712-4C29C04D-0CBE-47D9-84D4-F67421488A38Q34401421-272A03C9-5D80-44CF-9C22-29C287E3F067Q34461361-0370A421-178A-4180-BAB3-F5E1BC910694Q34590045-2A8BF679-B9BE-462D-961A-8A9E964C9AB5Q34672655-7EE3F1F8-81FB-4529-BD34-00F6C20D9979Q35099758-798C2A64-8B8A-4EAD-9B64-1BF9764FB3D5Q35134138-FE3CF0CE-BA03-4D25-A915-0A06121A5C93Q35628948-0ECBD899-6237-4E6B-AAFE-9777BC2C913DQ35662677-6398A56B-3A7B-4519-BF24-D790A904AB1AQ35879117-7A96C99D-FE14-4597-9E7C-762D3054822AQ35880537-F36FACB7-1F39-4FCF-809B-1ED9048F6F16Q35940556-C69D9E33-1685-4D53-B57E-198941C6F09FQ35959558-20F3E58A-21EA-49A7-9FC6-6D3C6774C6A4Q35991296-82FD6E94-E648-46B5-914E-F734FACCA518Q36082891-BBABD26F-BDB5-45E0-947C-2E0036AA9DC2Q36093598-02BDE65C-EA91-433D-9813-51DCCA7743CAQ36095086-70B31D1B-54AB-47BF-8A5E-DCD62796298EQ36161246-BCFA0D9A-C730-42D8-9B08-C2B789C54151Q36200911-03B6ABB6-E888-4C5D-8B21-D54251D72C0DQ36326251-A2610D65-B40D-493F-855C-529AF94F4E18Q36407206-A7F23228-2A5E-4022-93AE-55095E1B9682Q36409465-0C1245EC-D364-46CB-A214-625D344F92D4Q36422681-72BFDF7F-0F1E-4054-843E-C60D6B01C8A1Q36428418-34A8340E-3546-42AD-82F9-ACD6433649A5Q36520635-FEF0E52D-C86E-4544-93A8-3B95972A8DC3Q36548708-DA64FA07-8408-4F24-B3D6-8ACC1E570FB8Q36611653-36E4DF9A-6C67-4E99-B875-DA7127934CDCQ36636699-D4CC5146-9C93-430C-B29E-077890F0F983
P2860
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@ast
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@en
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@nl
type
label
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@ast
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@en
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@nl
prefLabel
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@ast
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@en
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@nl
P2093
P2860
P3181
P356
P1476
Bacteremic pneumonia due to St ...... hicillin-susceptible organisms
@en
P2093
González C
González M
Romero-Vivas J
P2860
P304
P3181
P356
10.1086/313440
P407
P577
1999-11-01T00:00:00Z